INDIVIOR PLC |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,435 GBX | 0.00% |
|
-0.21% | +21.27% |
| May. 03 | Deutsche Bank Kicks Off Indivior Coverage at Buy | MT |
| May. 03 | Jefferies cuts AJ Bell; Deutsche likes ConvaTec | AN |
Presenter SpeechJames Vane-Tempest (Analysts)I'm delighted to be here with you all this aftern...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Indivior PLC is a pharmaceutical company. The Company develops medicines to treat addiction and serious mental illnesses. The Company focuses on building a portfolio of opioid dependence treatments. It has a pipeline of product candidates designed to address other chronic conditions and co-occurring disorders of addiction, including alcohol use disorder. Its product pipeline focuses on development and discovery of non-opioid treatment strategies for opioid use disorder (OUD), as well as therapies to address the needs of people suffering from alcohol, stimulant, and cannabis use disorders. Its Sublocade, Subutex, and Suboxone are used for the treatment of opioid use disorder (OUD). Perseris is used for the treatment of Schizophrenia. The Company's pipeline products include AEF0117, INDV-2000, INDV-1000, RBP-6000, RBP-7000, Buprenorphine Sublingual and Naloxone Film, and Buprenorphine and Naloxone Sublingual Tablet. Its pipeline also includes the Orexin-1 Receptor Antagonist Program.
Sector
Pharmaceuticals
Calendar
07:00am
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
17.93
USD
Average target price
30.66
USD
Spread / Average Target
+71.01%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +21.27% | 2.43B | |
| +7.49% | 72.03B | |
| -10.86% | 5.14B | |
| +46.43% | 4.6B | |
| +5.38% | 3.96B | |
| -16.20% | 2.5B | |
| -26.20% | 2.32B | |
| +19.92% | 2.18B | |
| +8.15% | 1.72B | |
| -0.50% | 1.64B |
- Stock Market
- Equities
- INDV Stock
- News Indivior PLC
- Transcript : Indivior PLC - Special Call